Evaluation of phage-antibiotic combinations in the inactivation of urinary tract infection-related bacteria

Clicks: 30
ID: 326128
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #89 of 220 articles by views in Journal of applied microbiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 220 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims To evaluate the efficacy of bacteriophage–antibiotic combination therapy against major urinary tract infection (UTI) pathogens and determine whether combining phages with ciprofloxacin enhances bacterial killing, delays resistance emergence, and improves treatment performance under physiologically relevant conditions. Materials and Methods Five clinically relevant UTI pathogens were tested: Escherichia coli (UPEC), Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus mirabilis. Phages from a commercially available cocktail were screened and supplemented with a lab-isolated phage to improve E. coli coverage. In vitro assays evaluated bacterial inactivation using phages alone and in combination with ciprofloxacin at varying concentrations, including sub-MIC levels. Resistance emergence and associated fitness costs were assessed. Ex vivo efficacy was further tested using filtered human urine to simulate physiologically relevant conditions. Results Phage–antibiotic combinations significantly enhanced bacterial inactivation across all tested species compared to monotherapies, including at sub-MIC ciprofloxacin concentrations. Combination treatments delayed resistance development and imposed fitness costs on resistant E. coli mutants. Ex vivo urine assays confirmed that phages remained effective in physiologically relevant conditions, particularly in combination regimens, despite reduced antibiotic efficacy in urine. Conclusions Phage–antibiotic combination therapy improves bacterial killing, suppresses resistance emergence, and remains effective in urine-based models. These findings support integrating phage therapy with conventional antibiotics as a promising strategy for UTI management.
Reference Key
openalex_W7203991896 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors T F Leal, Pedro Costa, Carla Pereira, Adelaide Almeida
Are you one of these authors? Claim your profile
Journal Journal of applied microbiology
Year 2026
DOI
10.1093/jambio/lxag211
URL
https://doi.org/10.1093/jambio/lxag211
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.